FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)
Clinical trial NCT06187441 · RECRUITING
Trial details
- NCT number
- NCT06187441
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-14
- Primary completion
- 2031-01-01
- Enrollment
- 599
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.